Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
- PMID: 34782334
- PMCID: PMC8593703
- DOI: 10.1136/bmjdrc-2021-002407
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
Abstract
Introduction: The prevalence of type 2 diabetes mellitus (T2DM) is higher in peripheral artery disease (PAD) than in coronary artery disease (CAD) patients, and PAD overall confers higher cardiovascular risk than CAD. How cardiovascular risk compares between PAD and CAD patients when analyses are stratified by the presence of type 2 diabetes is unclear and is addressed in the present study.
Research design and methods: We prospectively recorded major cardiovascular events (MACE; ie, cardiovascular death, myocardial infarction or stroke) over 10.0±4.7 years in 923 patients with stable CAD, of whom 26.7% had T2DM and in 292 patients with PAD, of whom 42.1% had T2DM. Four groups were analyzed: CAD patients without diabetes (CAD/T2DM-; n=677), CAD patients with T2DM (CAD/T2DM+; n=246), PAD patients without diabetes (PAD/T2DM-; n=169) and PAD patients with T2DM (PAD/T2DM+; n=123).
Results: The event rate for MACE increased over our four investigated groups: it was lowest in CAD/T2DM- patients (2.52 events per 100 person-years). It was significantly higher in CAD/T2DM+ patients (3.96 events per 100 person-years; p<0.001), in PAD/T2DM- patients (3.68 events per 100 person-years; p=0.022), and in PAD/T2DM+ patients (7.10 events per 100 person-years; p<0.001), who in turn were at a higher risk than CAD/T2DM+ or PAD/T2DM- patients (p=0.001 and p<0.001, respectively). Cox regression analysis after multivariate adjustment showed that the presence of T2DM (HR=1.44 (95% CI 1.09 to 1.92); p=0.012) and the presence of PAD versus CAD (HR=1.48 (95% CI 1.15 to 1.91); p=0.002) were mutually independent predictors of cardiovascular events.
Conclusions: In conclusion, our data show that T2DM as well as the presence of PAD versus CAD are mutually independent predictors of MACE. Patients with both PAD and T2DM are at an exceedingly high risk of cardiovascular events.
Keywords: coronary artery disease; diabetes mellitus; peripheral arterial disease; risk factors; type 2.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study.Atherosclerosis. 2018 Dec;279:32-37. doi: 10.1016/j.atherosclerosis.2018.09.031. Epub 2018 Oct 6. Atherosclerosis. 2018. PMID: 30399464
-
Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.J Assoc Physicians India. 2012 Jul;60:28-32. J Assoc Physicians India. 2012. PMID: 23405538
-
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11. Vasc Med. 2018. PMID: 29992857 Clinical Trial.
-
The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.Cardiovasc Ther. 2016 Apr;34(2):115-24. doi: 10.1111/1755-5922.12169. Cardiovasc Ther. 2016. PMID: 26670723 Review.
-
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.Cardiovasc Ther. 2019 Nov 26;2019:8295054. doi: 10.1155/2019/8295054. eCollection 2019. Cardiovasc Ther. 2019. PMID: 32099582 Free PMC article. Review.
Cited by
-
Correlation between serum 25-hydroxyvitamin D level and peripheral arterial disease in patients with type 2 diabetes mellitus: a single-center retrospective study.Am J Transl Res. 2024 Aug 15;16(8):3759-3768. doi: 10.62347/YOBS2983. eCollection 2024. Am J Transl Res. 2024. PMID: 39262743 Free PMC article.
-
The Influence of Dapagliflozin on Foot Microcirculation in Patients with Type 2 Diabetes with and without Peripheral Arterial Disease-A Pilot Study.Pharmaceuticals (Basel). 2024 Aug 26;17(9):1127. doi: 10.3390/ph17091127. Pharmaceuticals (Basel). 2024. PMID: 39338292 Free PMC article.
-
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes.J Am Heart Assoc. 2025 Feb 4;14(3):e037863. doi: 10.1161/JAHA.124.037863. Epub 2025 Jan 23. J Am Heart Assoc. 2025. PMID: 39846296 Free PMC article.
-
Lesion Localization and Limb Outcomes in Elderly Patients with and Without Type 2 Diabetes Mellitus Who Undergo Atherectomy-Assisted Endovascular Revascularization due to Symptomatic Peripheral Artery Disease.J Clin Med. 2024 Oct 25;13(21):6385. doi: 10.3390/jcm13216385. J Clin Med. 2024. PMID: 39518525 Free PMC article.
-
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9. Cardiovasc Diabetol. 2024. PMID: 38926722 Free PMC article. Review.
References
-
- Low Wang CC, Hess CN, Hiatt WR, et al. . Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation 2016;133:2459–502. 10.1161/CIRCULATIONAHA.116.022194 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous